- High GHG emissions exposing the company to regulatory penalties and reputational damage.
- Material sourcing and efficiency risks leading to supply chain disruptions.
- Supplier environmental and social assessments revealing risks related to environmental standards and labor practices.
Aarti Pharmalabs Limited
Greenhouse gas emissions & sustainability report data
In its 2023-04 to 2024-03 reporting, Aarti Pharmalabs Limited disclosed greenhouse gas emissions of 183.9K tCO2e/year. By scope: Scope 1: 88.1K tCO2e/year; Scope 2: 95.8K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
183.9K tCO2e/year
2023-04 to 2024-03
Water Usage
391.9K KL/year
2023-04 to 2024-03
Waste
13.7K tons/year
2023-04 to 2024-03
Energy Use
1.3M GJ/year
2023-04 to 2024-03
📊 Emissions by Scope (2023-04 to 2024-03)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 88.1K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 95.8K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023-04 to 2024-03 | 183.9K tCO2e/year |
| 2022-23 | 117.1K tCO2e (Scope 1 & 2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Implemented Zero Liquid Discharge (ZLD) across all units.
- Underway with a solar energy project in Akola, Maharashtra (expected completion December 2024).
🌱 ESG Focus Areas
EnvironmentalSocialGovernance